RE:RE:RE:RE:RE:RE:what are we missing hereMeh, not sure I'd want them spending a lot of time/money on promotion like some greasy junior miner. The earnings are there, it's just a matter of waiting for people to take notice. That being said, I hope they are promoting Uracyst to other pharma companies around the world for licensing purposes. On a side tangent, I expect Q1 earnings to be monster.